Omentopexy versus Non-Omentopexy after Sleeve Gastrectomy: A Randomized Controlled Trial

Abstract

Background: Laparoscopic sleeve gastrectomy has been a common method performed exclusively for morbidly obese cases as an achieving weight loss means.

Objective: We aimed to compare outcome of omentopexy versus non-omentopexy in reducing of bleeding after sleeve gastrectomy.

Patients and Methods: This prospective randomized controlled trial was conducted on 64 morbid obese patients aged from 30 to 55  years old, both sexes, with body mass index (BMI) above 40 and were fit for general anesthesia and accepting participation in the  research. Participants were randomly allocated into two equal groups; group A were morbid obese participants underwent omentopexy  after sleeve gastrectomy and group B were morbid obese participants underwent non-omentopexy after sleeve gastrectomy.

Results:  Sex was significantly different between both groups with more prevalence of females in group A. The operative time was significantly  prolonged in group A in contrast to group B. Regarding the postoperative weight, and BMI change, the cases body weight in both group  A and B was significantly reduced during follow up (P<0.001). When comparing between both groups, the weight, and BMI at 1, 3, 6 and  12 months was significantly decreased in group A in contrast to group B (P<0.05).

Conclusions: The results detected that although the  procedure in group A was more time-consuming, it may have yielded superior long-term control overweight and BMI while maintaining  comparable safety profiles.